Compare Reddit Inc (RDDT) vs Viatris Inc (VTRS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Reddit Inc vs Viatris Inc — how do they compare? Reddit Inc trades at $170.13 (market cap $35.78B), while Viatris Inc trades at $17.02 (market cap $20.50B). The key difference: Reddit Inc is the larger of the two by market cap, and Viatris Inc pays a 2.73% dividend while Reddit Inc pays none. Which is the better fit depends on your goals.
| RDDT | VTRS | |
|---|---|---|
Market Cap | $35.78B | $20.50B |
Sector | Media | Health |
52-Week High | $270.71 | $17.59 |
52-Week Low | $121.84 | $8.74 |
Enterprise Value | $33.03B | $32.71B |
Dividend Yield | — | 2.73% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Reddit (RDDT) trades at $181.67, up 0.21% today, with a bearish technical signal but strong fundamentals including 91.37% gross margins and recent earnings beats. Analyst consensus is bullish with a $236.89 price target, and institutional interest is rising, as seen with Andra AP fonden's 152.6% stake increase in Q1 2026 (SEC filing, July 21, 2026).
The outlook is positive due to robust revenue growth and AI initiatives, but risks include high valuation multiples and competitive pressures. Near-term focus is on Q2 2026 earnings due July 30, 2026, which could drive volatility.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Reddit Inc
Reddit Inc. operates a vast network of online communities organized around various interests, known as 'subreddits'. Functioning as a hybrid of a social media platform and a discussion forum, the company generates revenue primarily through advertising and premium subscriptions. Reddit is a major hub for user-generated content, trending news, and viral discussions, and it is a key player in the digital advertising and social media landscape.
Read more on RDDT →About Viatris Inc
Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).
Read more on VTRS →
